Titilola Sode
Dermatopathology · Dallas, TXNPI 1003203381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 429 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 29.4% of the total.
Across 429 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pfizer$948
- Arcutis Biotherapeutics, Inc.$745
- Lilly USA, LLC$617
- Sanofi$610
- Johnson & Johnson$602
- plus $4K from 22 others
What the payments were for
- Food & beverage$10,82996%
- Education$4584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $3,313 |
| Pfizer | 33 | $948 |
| Arcutis Biotherapeutics, Inc. | 21 | $745 |
| Lilly USA, LLC | 21 | $617 |
| Sanofi | 22 | $610 |
| Johnson & Johnson | 18 | $602 |
| E.r. Squibb & Sons, L.L.C. | 28 | $597 |
| Regeneron Healthcare Solutions, Inc. | 22 | $594 |
| LEO Pharma Inc. | 27 | $569 |
| Sun Pharmaceutical Industries Inc. | 12 | $357 |
| Dermavant Sciences, Inc. | 8 | $313 |
| Organon | 10 | $298 |
| Amgen | 12 | $281 |
| Novartis | 7 | $245 |
| Galderma Laboratories, L.p. | 12 | $221 |
| UCB, Inc. | 5 | $204 |
| Incyte Corporation | 9 | $190 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Almirall LLC | 5 | $101 |
| Merz North America, Inc. | 1 | $94 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $60 |
| Boehringer Ingelheim | 2 | $36 |
| Botanix SB Inc | 2 | $35 |
| Springworks Therapeutics, Inc. | 1 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Krystal Biotech Inc | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,288 in reported general payments places this provider in the 80th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 45 | $1,535 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 20 | $1,179 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 22 | $640 |
| Triamcinolone Acetonide | 42 | $574 |
| Ketoconazole | 22 | $420 |
| Ammonium Lactate | 14 | $274 |
| Mupirocin | 18 | $154 |
| Hydrocortisone | 26 | $149 |
| Doxycycline Hyclate | 12 | $108 |
| Prednisone | 18 | $53 |
| Hydroxyzine Hcl | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Dallas
- Clay CockerellDallas$40K
- John WoffordDallas$11K
- Gregory HoslerDallas$3K
- Joseph SusaDallas$470
- Robert LawDallas$68
- Ryan HickDallas$50
- Angela MooreArlington$423K
- Melissa ChiangSpring$163K
- Alde GavinoLiberty Hill$110K
- Michael TetzlaffHoustion$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.